SUBSCRIBE
SUBSCRIBE
News   Deals

Helicos BioSciences Corporation Sets IPO at 5.4 Million Shares, $13-$15

May 8, 2007 | 
1 min read

WASHINGTON, May 7 (Reuters) - Helicos BioSciences Corp., a genetic analysis technologies firm, set its planned initial public offering on Monday at 5.4 million shares at between $13 and $15 per share.

>>> Discuss This Story

IPO
MORE ON THIS TOPIC
Podcast
A Conversation With Kevin Marks, CEO of Delphia
March 4, 2025
 · 
1 min read
 · 
Annalee Armstrong
Creative background
Deals
BridgeBio Oncology Takes Unexpected SPAC Track to Public Markets in $450M Deal
February 28, 2025
 · 
2 min read
 · 
Annalee Armstrong
Business
Money Meets Medicine: A Disruptor’s Guide to Life Sciences Investment
February 27, 2025
 · 
1 min read
 · 
Lori Ellis
Two human hands with a gesture of a handshake agreement and dollar banknotes with dollar signs on a colored background. Concept of business contract or agreement. Collage art
Editorial
The BioSpace Book Club Investigates the Biggest Deals of All Time
February 26, 2025
 · 
3 min read
 · 
Annalee Armstrong